nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP3A4—Thiotepa—sarcoma	0.121	0.404	CbGbCtD
Rivastigmine—CYP3A4—Mitoxantrone—sarcoma	0.0521	0.174	CbGbCtD
Rivastigmine—CYP3A4—Vincristine—sarcoma	0.0358	0.12	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—sarcoma	0.0352	0.118	CbGbCtD
Rivastigmine—CYP3A4—Etoposide—sarcoma	0.0328	0.11	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—sarcoma	0.0224	0.0748	CbGbCtD
Rivastigmine—Infestation—Epirubicin—sarcoma	0.000387	0.000552	CcSEcCtD
Rivastigmine—Infestation NOS—Epirubicin—sarcoma	0.000387	0.000552	CcSEcCtD
Rivastigmine—Drowsiness—Epirubicin—sarcoma	0.000387	0.000552	CcSEcCtD
Rivastigmine—Vomiting—Dactinomycin—sarcoma	0.000387	0.000552	CcSEcCtD
Rivastigmine—Rash—Thiotepa—sarcoma	0.000386	0.000551	CcSEcCtD
Rivastigmine—Bronchitis—Doxorubicin—sarcoma	0.000386	0.000551	CcSEcCtD
Rivastigmine—Dermatitis—Thiotepa—sarcoma	0.000386	0.000551	CcSEcCtD
Rivastigmine—Headache—Thiotepa—sarcoma	0.000384	0.000548	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000383	0.000547	CcSEcCtD
Rivastigmine—Rash—Dactinomycin—sarcoma	0.000383	0.000547	CcSEcCtD
Rivastigmine—Decreased appetite—Etoposide—sarcoma	0.000383	0.000546	CcSEcCtD
Rivastigmine—Renal failure—Epirubicin—sarcoma	0.00038	0.000543	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Etoposide—sarcoma	0.00038	0.000542	CcSEcCtD
Rivastigmine—Asthenia—Mitoxantrone—sarcoma	0.00038	0.000542	CcSEcCtD
Rivastigmine—Fatigue—Etoposide—sarcoma	0.000379	0.000542	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Epirubicin—sarcoma	0.000379	0.000541	CcSEcCtD
Rivastigmine—Pain—Etoposide—sarcoma	0.000376	0.000537	CcSEcCtD
Rivastigmine—Constipation—Etoposide—sarcoma	0.000376	0.000537	CcSEcCtD
Rivastigmine—Urinary tract infection—Epirubicin—sarcoma	0.000376	0.000537	CcSEcCtD
Rivastigmine—Conjunctivitis—Epirubicin—sarcoma	0.000376	0.000537	CcSEcCtD
Rivastigmine—Dysuria—Doxorubicin—sarcoma	0.000375	0.000536	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000373	0.000532	CcSEcCtD
Rivastigmine—Diarrhoea—Vincristine—sarcoma	0.000372	0.000531	CcSEcCtD
Rivastigmine—Sweating—Epirubicin—sarcoma	0.000371	0.000529	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—sarcoma	0.000371	0.000529	CcSEcCtD
Rivastigmine—Haematuria—Epirubicin—sarcoma	0.000369	0.000526	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000366	0.000523	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Epirubicin—sarcoma	0.000366	0.000522	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—sarcoma	0.000365	0.000521	CcSEcCtD
Rivastigmine—Epistaxis—Epirubicin—sarcoma	0.000365	0.000521	CcSEcCtD
Rivastigmine—Nausea—Thiotepa—sarcoma	0.000364	0.000519	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—sarcoma	0.000363	0.000518	CcSEcCtD
Rivastigmine—Sinusitis—Epirubicin—sarcoma	0.000363	0.000518	CcSEcCtD
Rivastigmine—Feeling abnormal—Etoposide—sarcoma	0.000363	0.000518	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—sarcoma	0.000362	0.000517	CcSEcCtD
Rivastigmine—Diarrhoea—Mitoxantrone—sarcoma	0.000362	0.000517	CcSEcCtD
Rivastigmine—Nausea—Dactinomycin—sarcoma	0.000361	0.000516	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—sarcoma	0.00036	0.000514	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Etoposide—sarcoma	0.00036	0.000514	CcSEcCtD
Rivastigmine—Dizziness—Vincristine—sarcoma	0.000359	0.000513	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—sarcoma	0.000358	0.000511	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—sarcoma	0.000358	0.000511	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—sarcoma	0.000358	0.000511	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000355	0.000506	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—sarcoma	0.000353	0.000505	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—sarcoma	0.000352	0.000502	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000351	0.000501	CcSEcCtD
Rivastigmine—Urticaria—Etoposide—sarcoma	0.00035	0.000499	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—sarcoma	0.000349	0.000498	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—sarcoma	0.000348	0.000497	CcSEcCtD
Rivastigmine—Body temperature increased—Etoposide—sarcoma	0.000348	0.000497	CcSEcCtD
Rivastigmine—Abdominal pain—Etoposide—sarcoma	0.000348	0.000497	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—sarcoma	0.000348	0.000497	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—sarcoma	0.000348	0.000497	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—sarcoma	0.000347	0.000496	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—sarcoma	0.000347	0.000496	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—sarcoma	0.000345	0.000493	CcSEcCtD
Rivastigmine—Vomiting—Vincristine—sarcoma	0.000345	0.000493	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—sarcoma	0.000345	0.000492	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—sarcoma	0.000343	0.00049	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—sarcoma	0.000343	0.000489	CcSEcCtD
Rivastigmine—Rash—Vincristine—sarcoma	0.000343	0.000489	CcSEcCtD
Rivastigmine—Dermatitis—Vincristine—sarcoma	0.000342	0.000488	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—sarcoma	0.000342	0.000488	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—sarcoma	0.000341	0.000487	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—sarcoma	0.000341	0.000487	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—sarcoma	0.00034	0.000486	CcSEcCtD
Rivastigmine—Headache—Vincristine—sarcoma	0.00034	0.000486	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000338	0.000483	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—sarcoma	0.000338	0.000482	CcSEcCtD
Rivastigmine—Vomiting—Mitoxantrone—sarcoma	0.000336	0.00048	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—sarcoma	0.000336	0.000479	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—sarcoma	0.000335	0.000478	CcSEcCtD
Rivastigmine—Rash—Mitoxantrone—sarcoma	0.000334	0.000476	CcSEcCtD
Rivastigmine—Dermatitis—Mitoxantrone—sarcoma	0.000333	0.000476	CcSEcCtD
Rivastigmine—Headache—Mitoxantrone—sarcoma	0.000331	0.000473	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—sarcoma	0.000328	0.000469	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—sarcoma	0.000327	0.000467	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—sarcoma	0.000324	0.000463	CcSEcCtD
Rivastigmine—Hypersensitivity—Etoposide—sarcoma	0.000324	0.000463	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—sarcoma	0.000324	0.000462	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—sarcoma	0.000323	0.000461	CcSEcCtD
Rivastigmine—Nausea—Vincristine—sarcoma	0.000323	0.000461	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—sarcoma	0.000322	0.00046	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—sarcoma	0.000322	0.00046	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—sarcoma	0.000322	0.00046	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—sarcoma	0.000321	0.000459	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—sarcoma	0.000321	0.000459	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—sarcoma	0.00032	0.000456	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—sarcoma	0.000319	0.000455	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—sarcoma	0.000317	0.000453	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—sarcoma	0.000317	0.000452	CcSEcCtD
Rivastigmine—Asthenia—Etoposide—sarcoma	0.000316	0.000451	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—sarcoma	0.000316	0.000451	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—sarcoma	0.000315	0.00045	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—sarcoma	0.000315	0.00045	CcSEcCtD
Rivastigmine—Nausea—Mitoxantrone—sarcoma	0.000314	0.000449	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—sarcoma	0.000313	0.000447	CcSEcCtD
Rivastigmine—Chills—Epirubicin—sarcoma	0.000312	0.000445	CcSEcCtD
Rivastigmine—Pruritus—Etoposide—sarcoma	0.000311	0.000444	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—sarcoma	0.00031	0.000443	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—sarcoma	0.00031	0.000442	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—sarcoma	0.000307	0.000438	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—sarcoma	0.000304	0.000434	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—sarcoma	0.000304	0.000434	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—sarcoma	0.000302	0.000431	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—sarcoma	0.000302	0.000431	CcSEcCtD
Rivastigmine—Diarrhoea—Etoposide—sarcoma	0.000301	0.00043	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—sarcoma	0.0003	0.000429	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—sarcoma	0.0003	0.000428	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—sarcoma	0.000298	0.000426	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—sarcoma	0.000298	0.000426	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—sarcoma	0.000298	0.000425	CcSEcCtD
Rivastigmine—Tension—Epirubicin—sarcoma	0.000297	0.000423	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—sarcoma	0.000296	0.000423	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—sarcoma	0.000294	0.000419	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—sarcoma	0.000292	0.000417	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—sarcoma	0.000291	0.000416	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—sarcoma	0.000291	0.000415	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—sarcoma	0.000291	0.000415	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—sarcoma	0.00029	0.000413	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—sarcoma	0.000288	0.000411	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—sarcoma	0.000287	0.00041	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—sarcoma	0.000285	0.000407	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—sarcoma	0.000284	0.000405	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—sarcoma	0.000281	0.000402	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—sarcoma	0.00028	0.0004	CcSEcCtD
Rivastigmine—Vomiting—Etoposide—sarcoma	0.00028	0.000399	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—sarcoma	0.00028	0.000399	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—sarcoma	0.00028	0.000399	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—sarcoma	0.000279	0.000399	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—sarcoma	0.000278	0.000396	CcSEcCtD
Rivastigmine—Rash—Etoposide—sarcoma	0.000277	0.000396	CcSEcCtD
Rivastigmine—Dermatitis—Etoposide—sarcoma	0.000277	0.000396	CcSEcCtD
Rivastigmine—Headache—Etoposide—sarcoma	0.000276	0.000394	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—sarcoma	0.000276	0.000393	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—sarcoma	0.000274	0.000392	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—sarcoma	0.000274	0.000391	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—sarcoma	0.000273	0.000389	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—sarcoma	0.000272	0.000388	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—sarcoma	0.000272	0.000388	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—sarcoma	0.000271	0.000387	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—sarcoma	0.000271	0.000386	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—sarcoma	0.000269	0.000384	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—sarcoma	0.000267	0.000381	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—sarcoma	0.000266	0.000379	CcSEcCtD
Rivastigmine—Cough—Epirubicin—sarcoma	0.000264	0.000376	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—sarcoma	0.000264	0.000376	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—sarcoma	0.000262	0.000374	CcSEcCtD
Rivastigmine—Nausea—Etoposide—sarcoma	0.000261	0.000373	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—sarcoma	0.000261	0.000372	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—sarcoma	0.000259	0.00037	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—sarcoma	0.000259	0.000369	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—sarcoma	0.000257	0.000367	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—sarcoma	0.000257	0.000367	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—sarcoma	0.000257	0.000367	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—sarcoma	0.000257	0.000367	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—sarcoma	0.000256	0.000366	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000256	0.000365	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—sarcoma	0.000254	0.000363	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—sarcoma	0.000252	0.00036	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—sarcoma	0.000252	0.000359	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—sarcoma	0.000251	0.000359	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—sarcoma	0.000251	0.000358	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—sarcoma	0.000249	0.000355	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—sarcoma	0.000247	0.000353	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—sarcoma	0.000247	0.000352	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—sarcoma	0.000246	0.000351	CcSEcCtD
Rivastigmine—Infection—Epirubicin—sarcoma	0.000245	0.00035	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—sarcoma	0.000244	0.000348	CcSEcCtD
Rivastigmine—Shock—Epirubicin—sarcoma	0.000243	0.000346	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—sarcoma	0.000242	0.000346	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—sarcoma	0.000242	0.000345	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—sarcoma	0.000242	0.000345	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—sarcoma	0.000241	0.000345	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—sarcoma	0.000241	0.000344	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—sarcoma	0.00024	0.000342	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—sarcoma	0.000238	0.00034	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—sarcoma	0.000238	0.00034	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—sarcoma	0.000238	0.00034	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—sarcoma	0.000238	0.00034	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—sarcoma	0.000237	0.000339	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000236	0.000338	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—sarcoma	0.000235	0.000336	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—sarcoma	0.000235	0.000336	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—sarcoma	0.000233	0.000332	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—sarcoma	0.000231	0.000329	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—sarcoma	0.00023	0.000329	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—sarcoma	0.000228	0.000326	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—sarcoma	0.000227	0.000324	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000225	0.000321	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—sarcoma	0.000225	0.000321	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—sarcoma	0.000224	0.00032	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—sarcoma	0.000223	0.000319	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—sarcoma	0.000223	0.000318	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—sarcoma	0.000223	0.000318	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—sarcoma	0.000222	0.000316	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—sarcoma	0.000222	0.000316	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—sarcoma	0.000221	0.000315	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—sarcoma	0.00022	0.000314	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—sarcoma	0.000219	0.000313	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—sarcoma	0.000218	0.000311	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—sarcoma	0.000217	0.00031	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—sarcoma	0.000214	0.000306	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—sarcoma	0.000213	0.000304	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000213	0.000304	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—sarcoma	0.000213	0.000304	CcSEcCtD
Rivastigmine—Pain—Epirubicin—sarcoma	0.000211	0.000301	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—sarcoma	0.000211	0.000301	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000208	0.000297	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—sarcoma	0.000206	0.000295	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—sarcoma	0.000205	0.000293	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—sarcoma	0.000204	0.00029	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—sarcoma	0.000203	0.00029	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—sarcoma	0.000203	0.00029	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—sarcoma	0.000202	0.000288	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—sarcoma	0.000201	0.000287	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—sarcoma	0.000198	0.000283	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000197	0.000281	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—sarcoma	0.000197	0.000281	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—sarcoma	0.000196	0.00028	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—sarcoma	0.000195	0.000279	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—sarcoma	0.000195	0.000279	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—sarcoma	0.000195	0.000278	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—sarcoma	0.000195	0.000278	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—sarcoma	0.000188	0.000268	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000187	0.000266	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—sarcoma	0.000182	0.000259	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—sarcoma	0.000181	0.000259	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—sarcoma	0.00018	0.000258	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—sarcoma	0.00018	0.000258	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—sarcoma	0.000177	0.000253	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—sarcoma	0.000175	0.000249	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—sarcoma	0.000169	0.000241	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—sarcoma	0.000168	0.00024	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—sarcoma	0.000164	0.000234	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—sarcoma	0.000163	0.000233	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—sarcoma	0.000161	0.000231	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—sarcoma	0.000157	0.000224	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—sarcoma	0.000156	0.000223	CcSEcCtD
Rivastigmine—Rash—Epirubicin—sarcoma	0.000156	0.000222	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—sarcoma	0.000155	0.000222	CcSEcCtD
Rivastigmine—Headache—Epirubicin—sarcoma	0.000155	0.000221	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—sarcoma	0.000151	0.000215	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—sarcoma	0.000147	0.000209	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—sarcoma	0.000145	0.000207	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—sarcoma	0.000144	0.000205	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—sarcoma	0.000144	0.000205	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—sarcoma	0.000143	0.000204	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—sarcoma	0.000136	0.000194	CcSEcCtD
